Nuveen LLC Takes Position in Proto Labs, Inc. $PRLB

Key Points

• Nuveen LLC acquired a new stake in Proto Labs, Inc. (NYSE:PRLB), purchasing 70,150 shares valued at approximately $2.46 million, which represents about 0.30% of the company's stock.
• Proto Labs recently reported a quarterly earnings per share (EPS) of $0.41, exceeding analysts' expectations of $0.33 and showing a 7.6% increase in revenue year-over-year, reaching $135.06 million.
• Research firms have upgraded Proto Labs' stock rating, with Wall Street Zen elevating it from "buy" to "strong-buy" and Cantor Fitzgerald raising the target price to $51.00.

Nuveen LLC acquired a new stake in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 70,150 shares of the industrial products company's stock, valued at approximately $2,458,000. Nuveen LLC owned about 0.30% of Proto Labs as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. GAMMA Investing LLC increased its position in Proto Labs by 249.4% during the first quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 661 shares during the last quarter. Quarry LP increased its position in Proto Labs by 175.7% during the fourth quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock valued at $62,000 after acquiring an additional 1,010 shares during the last quarter. CWM LLC increased its position in Proto Labs by 50.4% during the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock valued at $64,000 after acquiring an additional 617 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Proto Labs by 14.1% during the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock valued at $76,000 after acquiring an additional 267 shares during the last quarter. Finally, Lazard Asset Management LLC increased its position in Proto Labs by 182.3% during the fourth quarter. Lazard Asset Management LLC now owns 5,875 shares of the industrial products company's stock valued at $228,000 after acquiring an additional 3,794 shares during the last quarter. Hedge funds and other institutional investors own 84.54% of the company's stock.

Insider Buying and Selling

In related news, CEO Suresh Krishna purchased 1,725 shares of the firm's stock in a transaction on Monday, August 4th. The shares were acquired at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the purchase, the chief executive officer directly owned 18,021 shares in the company, valued at $784,093.71. This trade represents a 10.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms recently commented on PRLB. Wall Street Zen upgraded Proto Labs from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Craig Hallum upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research note on Friday, August 1st. Finally, Cantor Fitzgerald lifted their target price on Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $52.50.

Proto Labs Trading Down 2.1%

NYSE PRLB traded down $1.08 on Monday, hitting $49.69. 207,182 shares of the company traded hands, compared to its average volume of 185,243. The company has a market capitalization of $1.19 billion, a price-to-earnings ratio of 82.81 and a beta of 1.27. The business's 50 day moving average price is $43.50 and its 200-day moving average price is $39.51. Proto Labs, Inc. has a 52-week low of $26.34 and a 52-week high of $51.09.

Proto Labs (NYSE:PRLB - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.08. The company had revenue of $135.06 million for the quarter, compared to the consensus estimate of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.Proto Labs's quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.38 earnings per share. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. As a group, sell-side analysts predict that Proto Labs, Inc. will post 0.81 earnings per share for the current year.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.